Search
for

    Glossary Bromocriptine

    medication that acts as a dopamine agonist

    Bromocriptine, also known by the brand name Parlodel, is a medication that primarily acts as a dopamine agonist. It is used to treat conditions like Parkinson's disease, hyperprolactinemia (high levels of prolactin), and type 2 diabetes. By stimulating dopamine receptors in the brain, it helps to reduce the production of prolactin and improve motor function in Parkinson's patients.

    Sort by

    Research 30 of 136

    1. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea International Journal of Gynecology & Obstetrics · 1995
    2. Impaired Cardiometabolic Effects of Bromocriptine in Men With Early‐Onset Androgenic Alopecia The Journal of Clinical Pharmacology · 2022
    3. Evaluation of melatonin and bromocryptine administration in Spanish goats Small ruminant research · 2005 · 10 citations
    4. The role of prolactin in the reactivation of hair follicles in relation to moulting in cashmere goats 1994 · 62 citations
    5. Prolactin delays hair regrowth in mice Journal of Endocrinology · 2006 · 53 citations
    6. Alopecia induced by dopamine agonists Neurology · 2002 · 21 citations
    7. Inhibition of prolactin promotes secondary skin follicle activation in cashmere goats 2021 · 7 citations
    8. Finasteride and male fertility Journal of Human Reproductive Sciences · 2011 · 1 citations
    9. Wanita 28 Tahun dengan Hyperprolactinemia dan Hubungan terhadap Policystic Ovary Syndrome Manuju · 2023
    10. 24. 力発揮および操作性からみた下肢運動の一側優位性(神経・感覚,一般口演,第63回日本体力医学会大会) 体力科學 · 2008
    11. Current Management and Treatment Options for Breast Pain Mayo Clinic Proceedings · 2020 · 19 citations
    12. Pramipexole Elsevier eBooks · 2015
    13. Hair Loss as a Side Effect of Lamotrigine Treatment American Journal of Psychiatry · 2006 · 9 citations
    14. Drug Reactions Affecting Hair: Diagnosis Dermatologic Clinics · 2007 · 85 citations
    15. Dopamine is a novel, direct inducer of catagen in human scalp hair follicles<i>in vitro</i> British Journal of Dermatology · 2012 · 19 citations
    16. Asymptomatic hyperprolactinemia resulting from macroprolactemia Fertility and Sterility · 1990 · 14 citations
    17. Telogen effluvium treated with Serenoa repens supplement Senses and Sciences · 2014 · 1 citations
    18. Effect of inhibiting prolactin secretion on secondary hair follicle development in cashmere goats Animal Bioscience · 2025
    19. Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment Research Journal for Social Affairs · 2024
    20. Oral contraceptives and risk of breast cancer in women aged 20–54 years International Journal of Gynecology & Obstetrics · 1995
    21. The dose‐response of percutaneous oestradiol implants on the skeletons of postmenopausal women International Journal of Gynecology & Obstetrics · 1995
    22. Drug-induced changes in hair growth Drugs & Therapy Perspectives · 1994
    23. The Neurobiology of Sexual Function Archives of General Psychiatry · 2000 · 393 citations
    24. Telogen Effluvium Archives of Dermatology · 1993 · 214 citations
    25. Drug-Induced Hair Loss and Hair Growth Drug Safety · 1994 · 147 citations
    26. Human Scalp Hair Follicles Are Both a Target and a Source of Prolactin, which Serves as an Autocrine and/or Paracrine Promoter of Apoptosis-Driven Hair Follicle Regression American Journal of Pathology · 2006 · 128 citations
    27. Hormesis and medicine British Journal of Clinical Pharmacology · 2008 · 127 citations
    28. Biochemical and trichological characterization of diffuse alopecia in women British Journal of Dermatology · 1990 · 124 citations
    29. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review American Journal of Clinical Dermatology · 2017 · 117 citations
    30. Biology of the wool follicle: an excursion into a unique tissue interaction system waiting to be re‐discovered Experimental Dermatology · 2006 · 117 citations